Specialty journal
The Curette Oncology
Oncology
Research across cancer biology, prevention, diagnosis, treatment, supportive care, outcomes, and survivorship.
Journal Overview
The Curette Oncology provides a focused forum for research spanning the cancer continuum, from biologically grounded discovery to clinical care and survivorship.
It connects laboratory, translational, clinical, computational, and population perspectives that contribute to understanding malignancy or improving cancer care.
Latest Articles
No articles published yet.
Newly published articles will appear here.
Current Issue
No current issue has been published yet.
The current issue will appear here after publication.
All Issues / Archive
No issues published yet.
Past volumes and issues will be available here as the archive grows.
Aims & Scope
The journal welcomes cancer and tumor biology, molecular oncology, genetics and genomics, biomarkers, pathology, imaging, liquid biopsy, and precision oncology. Translational studies should connect biological insight or analytical methods with a meaningful oncology question.
Clinical scope includes medical, surgical, and radiation oncology; immuno-oncology and targeted therapy; resistance, metastasis, tumor microenvironment, trials, outcomes, supportive and palliative oncology, and survivorship. Prevention and epidemiology are welcomed when cancer is central.
Readers include cancer researchers, oncologists, surgeons, pathologists, radiologists, trialists, allied professionals, and population scientists. Computational work should include appropriate biological or clinical validation.
Scope boundary
Studies using cancer datasets without a substantive oncology question or adequate validation are outside scope. General health-system work should make its cancer relevance clear.
Topics / Subject Coverage
Representative areas include the following. This list guides journal selection but is not a keyword checklist or a substitute for editorial assessment.
- Cancer and tumor biology
- Molecular oncology
- Cancer genetics and genomics
- Biomarkers and precision oncology
- Pathology and imaging
- Medical, surgical, and radiation oncology
- Immuno-oncology
- Targeted therapies and resistance
- Metastasis and tumor microenvironment
- Liquid biopsy
- Clinical trials
- Supportive and palliative care
- Survivorship
- Cancer epidemiology and prevention
- Computational oncology
Relevant approaches
- Laboratory and translational studies
- Clinical trials
- Biomarker and diagnostic studies
- Molecular and genomic analyses
- Outcomes and real-world evidence
- Evidence synthesis
Editorial Information
Editorial information will be displayed as appointments are formally confirmed. No editor, affiliation, credential, or board membership should be inferred before verified information appears here.
Editorial decisions are independent and based on scope, scholarly merit, research integrity, ethical compliance, and the evidence available through assessment and review.
Journal Policies
This journal follows The Curette’s platform-wide policies: Gold Open Access, author-retained copyright, a Version of Record normally licensed under CC BY 4.0, single-blind peer review, and continuous publication. An APC is payable only after formal acceptance: ₹5,999 for India billing locations or US$199 outside India. There is no submission fee, and payment cannot influence or guarantee an editorial outcome.